retatrutide mechanism glp-1 gip glucagon triple agonist The Road towards Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Receptor Dual and Triple Gut Peptide

Annu Rev Entomol 42:611643

Retatrutides aggressive caloric reduction creates conditions that typically cause muscle loss

This single compound can reduce inflammation and oxidative stress, speed the healing of tendons and ligaments, support nerve repair and even improve gut integrity

Borenstein is a big believer in getting patients to complete remission or as low disease activity as possible

Recent statistical analyses indicate that approximately 20 million new cancer cases and 9.7 million deaths were reported globally in 2022, and this number is projected to rise substantially in the coming decades, potentially exceeding 35 million cases by 2050 (1)